ULTRAVIST 370 iopromide 384.5 g/500 mL solution for injection bottle Australia - English - Department of Health (Therapeutic Goods Administration)

ultravist 370 iopromide 384.5 g/500 ml solution for injection bottle

bayer australia ltd - iopromide, quantity: 768.86 mg/ml - injection, solution - excipient ingredients: dilute hydrochloric acid; sodium calcium edetate; trometamol; water for injections; sodium hydroxide - ultravist is indicated for all angiographic and urographic examinations and for contrast enhancement in computerised tomography.,ultravist 300 or 370 is indicated for use in contrast-enhanced mammography (cem) in adults, to visualise known or suspected lesions of the breast as an adjunct to mammography (with or without ultrasound).

LEVISTICUM E RAD. 3- levisticum e rad. 3 liquid United States - English - NLM (National Library of Medicine)

levisticum e rad. 3- levisticum e rad. 3 liquid

uriel pharmacy inc. - levisticum officinale root (unii: 46qz19oex8) (levisticum officinale root - unii:46qz19oex8) - levisticum officinale root 3 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of ear irritation.

LEVISTICUM QUERCUS- levisticum quercus liquid United States - English - NLM (National Library of Medicine)

levisticum quercus- levisticum quercus liquid

uriel pharmacy inc. - levisticum officinale root (unii: 46qz19oex8) (levisticum officinale root - unii:46qz19oex8), quercus robur whole (unii: r7qmg0bt2w) (quercus robur whole - unii:r7qmg0bt2w), bos taurus eye (unii: vtw461n43p) (bos taurus eye - unii:vtw461n43p), bos taurus nerve (unii: 28g2u3mqjk) (bos taurus nerve - unii:28g2u3mqjk) - levisticum officinale root 6 [hp_x] in 1 ml - directions: for oral use. use: temporary relief of skin rash.

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 10mL injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 10ml injection pre-filled syringe

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; trisodium caloxetate; trometamol; hydrochloric acid; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 7.5mL injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 7.5ml injection pre-filled syringe

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: trometamol; sodium hydroxide; hydrochloric acid; water for injections; trisodium caloxetate - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 10mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 10ml injection vial

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: hydrochloric acid; trisodium caloxetate; water for injections; sodium hydroxide; trometamol - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 7.5mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 7.5ml injection vial

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: trisodium caloxetate; sodium hydroxide; trometamol; water for injections; hydrochloric acid - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 5mL injection pre-filled syringe Australia - English - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 5ml injection pre-filled syringe

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; hydrochloric acid; trisodium caloxetate; trometamol; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion

PRIMOVIST disodium gadoxetate 181.43 mg/mL (0.25M) 5mL injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

primovist disodium gadoxetate 181.43 mg/ml (0.25m) 5ml injection vial

bayer australia ltd - disodium gadoxetate, quantity: 181.43 mg/ml - injection, solution - excipient ingredients: water for injections; trometamol; trisodium caloxetate; hydrochloric acid; sodium hydroxide - this medicinal product is for diagnostic use only. primovist is indicated for use in adults for the enhancement of magnetic resonance imaging (mri) of focal liver lesion